Ginkgo Bioworks Holdings Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while Invesco WilderHill Clean Energy ETF trades at $34.98. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | PBW | |
|---|---|---|
Market Cap | $590.53M | — |
Sector | Health | Sector/Thematic |
52-Week High | $16.14 | $46.99 |
52-Week Low | $5.48 | $22.23 |
Enterprise Value | $627.78M | — |
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
PBW (Invesco WilderHill Clean Energy ETF) trades at $34.00, down 3.46% with a bearish technical signal from moving averages. The ETF shows oversold conditions with RSI readings below 30, while clean energy sector news highlights both volatility and growth potential driven by energy security concerns and data center demand. Recent articles note PBW's 34% year-to-date gains but caution about rate cycle sensitivity.
Outlook remains mixed with technical weakness offset by clean energy tailwinds. Investment opportunity lies in global energy transition trends, but risks include interest rate sensitivity and sector volatility. The ETF's performance is heavily influenced by macroeconomic factors rather than individual company fundamentals.
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →